Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Muñoz-Fernández MA[au]:

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers. Dominguez-Molina B et al. Front Immunol. (2018)

Dendritic Cells, the Double Agent in the War Against HIV-1. Martín-Moreno A et al. Front Immunol. (2019)

Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. Pernas M et al. J Virol. (2018)

Search results

Items: 1 to 50 of 411

1.

Gold Nanoparticles Crossing Blood-Brain Barrier Prevent HSV-1 Infection and Reduce Herpes Associated Amyloid-βsecretion.

I RI, Mj S, R G, Fj M, Mj B, Ma MF.

J Clin Med. 2020 Jan 7;9(1). pii: E155. doi: 10.3390/jcm9010155.

2.

Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.

Fernández IC, Merino IG, Muñoz-Fernández MÁ.

J Transl Med. 2020 Jan 6;18(1):6. doi: 10.1186/s12967-019-02187-w.

3.

Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth.

Domínguez-Rodríguez S, Tagarro A, Palma P, Foster C, Puthanakit T, Jupimai T, Cotugno N, Ananworanich J, Zangari P, Nastouli E, Muñoz-Fernández MÁ, Navarro ML, Giaquinto C, Rossi P, Kuhn L, Rojo P.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):483-490. doi: 10.1097/QAI.0000000000002188.

PMID:
31714427
4.

Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide.

Guerrero-Beltrán C, Prieto A, Leal M, Jiménez JL, Muñoz-Fernández MÁ.

Future Med Chem. 2019 Dec;11(23):3005-3013. doi: 10.4155/fmc-2018-0539. Epub 2019 Nov 11.

PMID:
31710246
5.

Dendritic Cells, the Double Agent in the War Against HIV-1.

Martín-Moreno A, Muñoz-Fernández MA.

Front Immunol. 2019 Oct 23;10:2485. doi: 10.3389/fimmu.2019.02485. eCollection 2019. Review.

6.

How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain.

Suárez-García I, Alejos B, Delgado E, Rivero M, Pineda JA, Jarrin I; Cohort of the Spanish HIV/AIDS Network (CoRIS) study group.

HIV Med. 2020 Feb;21(2):128-134. doi: 10.1111/hiv.12817. Epub 2019 Nov 8.

PMID:
31702111
7.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

Suárez-García I, Ruiz-Algueró M, García Yubero C, Moreno C, Belza MJ, Estébanez M, de Los Santos I, Masiá M, Samperiz Abad G, Muñoz Sánchez J, Omar M, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS) .

J Antimicrob Chemother. 2020 Feb 1;75(2):466-472. doi: 10.1093/jac/dkz439.

PMID:
31665404
8.

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015.

Jiménez de Ory S, Ramos JT, Fortuny C, González-Tomé MI, Mellado MJ, Moreno D, Gavilán C, Menasalvas AI, Piqueras AI, Frick MA, Muñoz-Fernández MA, Navarro ML; CoRISpe Cohort Working Group.

PLoS One. 2019 Oct 24;14(10):e0223536. doi: 10.1371/journal.pone.0223536. eCollection 2019.

9.

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study.

Jiménez-Sousa MÁ, Jiménez JL, Fernández-Rodríguez A, Bellón JM, Rodríguez C, Riera M, Portilla J, Castro Á, Muñoz-Fernández MÁ, Resino S.

J Biomed Sci. 2019 Oct 23;26(1):83. doi: 10.1186/s12929-019-0577-y.

10.

Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children.

Guillén S, Prieto L, Jiménez de Ory S, González-Tomé MI, Rojo P, Navarro ML, Mellado MJ, Escosa L, Sainz T, Francisco L, Muñoz-Fernández MÁ, Ramos JT; CoRISpe (Cohorte Nacional de VIH pediátrica de la RED RIS).

PLoS One. 2019 Aug 5;14(8):e0220552. doi: 10.1371/journal.pone.0220552. eCollection 2019.

11.

Dendronized magnetic nanoparticles for HIV-1 capture and rapid diagnostic.

Barrios-Gumiel A, Sepúlveda-Crespo D, Jiménez JL, Gómez R, Muñoz-Fernández MÁ, de la Mata FJ.

Colloids Surf B Biointerfaces. 2019 Sep 1;181:360-368. doi: 10.1016/j.colsurfb.2019.05.050. Epub 2019 May 23.

PMID:
31158698
12.

Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects.

Genebat M, Tarancón-Díez L, Pulido I, Álvarez-Ríos AI, Muñoz-Fernández MÁ, Ruiz-Mateos E, Leal M.

Antiviral Res. 2019 Sep;169:104527. doi: 10.1016/j.antiviral.2019.05.016. Epub 2019 May 31.

PMID:
31158414
13.

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.

Relaño-Rodríguez I, Juárez-Sánchez R, Pavicic C, Muñoz E, Muñoz-Fernández MÁ.

J Nanobiotechnology. 2019 May 21;17(1):69. doi: 10.1186/s12951-019-0500-4.

14.

G2-S16 dendrimer microbicide does not interfere with the vaginal immune system.

Martín-Moreno A, Sepúlveda-Crespo D, Serramía-Lobera MJ, Perisé-Barrios AJ, Muñoz-Fernández MA.

J Nanobiotechnology. 2019 May 15;17(1):65. doi: 10.1186/s12951-019-0496-9.

15.

New anionic poly(alkylideneamine) dendrimers as microbicide agents against HIV-1 infection.

Maciel D, Guerrero-Beltrán C, Ceña-Diez R, Tomás H, Muñoz-Fernández MÁ, Rodrigues J.

Nanoscale. 2019 May 16;11(19):9679-9690. doi: 10.1039/c9nr00303g.

PMID:
31066407
16.

G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity.

Ceña-Diez R, Martin-Moreno A, de la Mata FJ, Gómez-Ramirez R, Muñoz E, Ardoy M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2019 Apr 2;14:2371-2381. doi: 10.2147/IJN.S188495. eCollection 2019.

17.

Poly(N-vinylcaprolactam) Nanogels with Antiviral Behavior against HIV-1 Infection.

Macchione MA, Guerrero-Beltrán C, Rosso AP, Euti EM, Martinelli M, Strumia MC, Muñoz-Fernández MÁ.

Sci Rep. 2019 Apr 5;9(1):5732. doi: 10.1038/s41598-019-42150-9.

18.

Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.

Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

PLoS One. 2019 Mar 27;14(3):e0213744. doi: 10.1371/journal.pone.0213744. eCollection 2019.

19.

VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients.

Jiménez-Sousa MA, Jiménez JL, Fernández-Rodríguez A, Brochado-Kith O, Bellón JM, Gutierrez F, Díez C, Bernal-Morell E, Viciana P, Muñoz-Fernández MA, Resino S.

J Clin Med. 2019 Mar 5;8(3). pii: E311. doi: 10.3390/jcm8030311.

20.

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.

Dominguez-Molina B, Ferrando-Martinez S, Tarancon-Diez L, Hernandez-Quero J, Genebat M, Vidal F, Muñoz-Fernandez MA, Leal M, Koup R, Ruiz-Mateos E.

Front Immunol. 2018 Dec 10;9:2897. doi: 10.3389/fimmu.2018.02897. eCollection 2018.

21.

[Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform].

Calvo C, Sainz T, Codoñer-Franch P, Santiago B, García-García ML, García Vera C, Muñoz-Fernandez MA, Pérez-Martínez A, Rivero I, Fernandez Pérez C, Mejías A, Martinón-Torres F, Cabañas F.

An Pediatr (Barc). 2018 Nov;89(5):314.e1-314.e6. doi: 10.1016/j.anpedi.2018.09.001. Epub 2018 Oct 9. Spanish.

22.

Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.

Tagarro A, Chan M, Zangari P, Ferns B, Foster C, De Rossi A, Nastouli E, Muñoz-Fernández MA, Gibb D, Rossi P, Giaquinto C, Babiker A, Fortuny C, Freguja R, Cotugno N, Judd A, Noguera-Julian A, Navarro ML, Mellado MJ, Klein N, Palma P, Rojo P.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):269-276. doi: 10.1097/QAI.0000000000001789.

23.

CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Correa-Rocha R, Lopez-Abente J, Gutierrez C, Pérez-Fernández VA, Prieto-Sánchez A, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

PLoS One. 2018 Aug 30;13(8):e0203419. doi: 10.1371/journal.pone.0203419. eCollection 2018.

24.

HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation.

Rosado-Sánchez I, Herrero-Fernández I, Genebat M, Del Romero J, Riera M, Podzamczer D, Olalla J, Vidal F, Muñoz-Fernández MA, Leal M, Pacheco YM.

Front Immunol. 2018 Jul 18;9:1673. doi: 10.3389/fimmu.2018.01673. eCollection 2018.

25.

High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.

Gutiérrez-Rivas M, Jiménez-Sousa MÁ, Rallón N, Jiménez JL, Restrepo C, León A, Montero-Alonso M, González-García J, Muñoz-Fernández MÁ, Benito JM, Resino S; ECRIS Integrated in the Spanish AIDS Research Network.

Front Immunol. 2018 Jun 18;9:1399. doi: 10.3389/fimmu.2018.01399. eCollection 2018.

26.

Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children.

Tagarro A, Chan M, Zangari P, Ferns B, Foster C, De Rossi A, Nastouli E, Muñoz-Fernández MA, Gibb D, Rossi P, Giaquinto C, Babiker A, Fortuny C, Freguja R, Cotugno N, Judd A, Noguera-Julian A, Navarro ML, Mellado MJ, Klein N, Palma P, Rojo P; EPIICAL Consortium.

J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001789. [Epub ahead of print]

PMID:
29957674
27.

Estrogen Receptor-Alpha (ESR1) Governs the Lower Female Reproductive Tract Vulnerability to Candida albicans.

Salinas-Muñoz L, Campos-Fernández R, Mercader E, Olivera-Valle I, Fernández-Pacheco C, Matilla L, García-Bordas J, Brazil JC, Parkos CA, Asensio F, Muñoz-Fernández MA, Hidalgo A, Sánchez-Mateos P, Samaniego R, Relloso M.

Front Immunol. 2018 May 24;9:1033. doi: 10.3389/fimmu.2018.01033. eCollection 2018.

28.

Sulfonate-ended carbosilane dendrimers with a flexible scaffold cause inactivation of HIV-1 virions and gp120 shedding.

Sepúlveda-Crespo D, de la Mata FJ, Gómez R, Muñoz-Fernández MA.

Nanoscale. 2018 May 17;10(19):8998-9011. doi: 10.1039/c8nr01664j.

PMID:
29726564
29.

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Bártolo I, Diniz AR, Borrego P, Ferreira JP, Bronze MR, Barroso H, Pinto R, Cardoso C, Pinto JF, Diaz RC, Broncano PG, Muñoz-Fernández MA, Taveira N.

PLoS One. 2018 May 2;13(5):e0197015. doi: 10.1371/journal.pone.0197015. eCollection 2018.

30.

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Bártolo I, Diniz AR, Borrego P, Ferreira JP, Bronze MR, Barroso H, Pinto R, Cardoso C, Pinto JF, Diaz RC, Broncano PG, Muñoz-Fernández MA, Taveira N.

PLoS One. 2018 Apr 18;13(4):e0195744. doi: 10.1371/journal.pone.0195744. eCollection 2018. Erratum in: PLoS One. 2018 May 2;13(5):e0197015.

31.

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.

Puertas MC, Gómez-Mora E, Santos JR, Moltó J, Urrea V, Morón-López S, Hernández-Rodríguez A, Marfil S, Martínez-Bonet M, Matas L, Muñoz-Fernández MA, Clotet B, Blanco J, Martinez-Picado J.

J Antimicrob Chemother. 2018 Jul 1;73(7):1940-1948. doi: 10.1093/jac/dky106.

32.

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Guardo AC, Gómez CE, Díaz-Brito V, Pich J, Arnaiz JA, Perdiguero B, García-Arriaza J, González N, Sorzano COS, Jiménez L, Jiménez JL, Muñoz-Fernández MÁ, Gatell JM, Alcamí J, Esteban M, de Quirós JCLB, García F, Plana M; RISVAC02boost study.

PLoS One. 2018 Apr 10;13(4):e0195915. doi: 10.1371/journal.pone.0195915. eCollection 2018.

33.

Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.

Guerrero-Beltran C, Rodriguez-Izquierdo I, Serramia MJ, Araya-Durán I, Márquez-Miranda V, Gomez R, de la Mata FJ, Leal M, González-Nilo F, Muñoz-Fernández MA.

Bioconjug Chem. 2018 May 16;29(5):1584-1594. doi: 10.1021/acs.bioconjchem.8b00106. Epub 2018 Mar 30.

PMID:
29570280
34.

Role of toll-like receptor 4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients.

Tarancon-Diez L, De Pablo-Bernal RS, Jiménez JL, Álvarez-Ríos AI, Genebat M, Rosado-Sánchez I, Muñoz-Fernández MÁ, Ruiz-Mateos E, Leal M.

AIDS. 2018 May 15;32(8):1035-1041. doi: 10.1097/QAD.0000000000001797.

PMID:
29547441
35.

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.

Benito JM, Ortiz MC, León A, Sarabia LA, Ligos JM, Montoya M, Garcia M, Ruiz-Mateos E, Palacios R, Cabello A, Restrepo C, Rodriguez C, Del Romero J, Leal M, Muñoz-Fernández MA, Alcamí J, García F, Górgolas M, Rallón N; ECRIS integrated in the Spanish AIDS Research Network.

BMC Med. 2018 Feb 28;16(1):30. doi: 10.1186/s12916-018-1026-6.

36.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group.

AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.

PMID:
29438197
37.

HIV-1 increases extracellular amyloid-beta levels through neprilysin regulation in primary cultures of human astrocytes.

Martínez-Bonet M, Muñoz-Fernández MÁ, Álvarez S.

J Cell Physiol. 2019 May;234(5):5880-5887. doi: 10.1002/jcp.26462. Epub 2018 Dec 7.

PMID:
29323711
38.

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

Gonzalez-Serna A, Ferrando-Martinez S, Tarancon-Diez L, De Pablo-Bernal RS, Dominguez-Molina B, Jiménez JL, Muñoz-Fernández MÁ, Leal M, Ruiz-Mateos E.

J Transl Med. 2017 Dec 20;15(1):259. doi: 10.1186/s12967-017-1367-5.

39.

Study of non-covalent interactions on dendriplex formation: Influence of hydrophobic, electrostatic and hydrogen bonds interactions.

Sánchez-Milla M, Pastor I, Maly M, Serramía MJ, Gómez R, Sánchez-Nieves J, Ritort F, Muñoz-Fernández MÁ, de la Mata FJ.

Colloids Surf B Biointerfaces. 2018 Feb 1;162:380-388. doi: 10.1016/j.colsurfb.2017.12.009. Epub 2017 Dec 8.

PMID:
29241096
40.

Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.

Ruiz-Mateos E, Tarancon-Diez L, Alvarez-Rios AI, Dominguez-Molina B, Genebat M, Pulido I, Abad MA, Muñoz-Fernandez MA, Leal M.

Antiviral Res. 2018 Feb;150:15-19. doi: 10.1016/j.antiviral.2017.12.002. Epub 2017 Dec 6.

PMID:
29221798
41.

Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection.

Guerrero-Beltrán C, Ceña-Diez R, Sepúlveda-Crespo D, De la Mata J, Gómez R, Leal M, Muñoz-Fernández MA, Jiménez JL.

Nanoscale. 2017 Nov 16;9(44):17263-17273. doi: 10.1039/c7nr05859d.

PMID:
29090302
42.

Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response.

Herrero-Fernández I, Pacheco YM, Genebat M, Rodriguez-Méndez MDM, Lozano MDC, Polaino MJ, Rosado-Sánchez I, Tarancón-Diez L, Muñoz-Fernández MÁ, Ruiz-Mateos E, Leal M.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02050-17. doi: 10.1128/AAC.02050-17. Print 2018 Jan.

43.

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Guardo AC, Gómez CE, Díaz-Brito V, Pich J, Arnaiz JA, Perdiguero B, García-Arriaza J, González N, Sorzano COS, Jiménez L, Jiménez JL, Muñoz-Fernández MÁ, Gatell JM, Alcamí J, Esteban M, López Bernaldo de Quirós JC, García F, Plana M; RISVAC02boost study.

PLoS One. 2017 Oct 24;12(10):e0186602. doi: 10.1371/journal.pone.0186602. eCollection 2017. Erratum in: PLoS One. 2018 Apr 10;13(4):e0195915.

44.

New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013.

Jiménez de Ory S, González-Tomé MI, Fortuny C, Mellado MJ, Soler-Palacin P, Bustillo M, Ramos JT, Muñoz-Fernández MA, Navarro ML; Working groups of CoRISpe.

Medicine (Baltimore). 2017 Sep;96(39):e7858. doi: 10.1097/MD.0000000000007858.

45.

CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels.

Rocha-Perugini V, Suárez H, Álvarez S, López-Martín S, Lenzi GM, Vences-Catalán F, Levy S, Kim B, Muñoz-Fernández MA, Sánchez-Madrid F, Yáñez-Mó M.

Nat Microbiol. 2017 Nov;2(11):1513-1522. doi: 10.1038/s41564-017-0019-0. Epub 2017 Sep 4.

46.

New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection.

Moreno S, Sepúlveda-Crespo D, de la Mata FJ, Gómez R, Muñoz-Fernández MÁ.

Antiviral Res. 2017 Oct;146:54-64. doi: 10.1016/j.antiviral.2017.08.009. Epub 2017 Aug 18.

PMID:
28827122
47.

Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion.

Gonzalez-Serna A, Ajaykumar A, Gadawski I, Muñoz-Fernández MA, Hayashi K, Harrigan PR, Côté HCF.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e29-e32. doi: 10.1097/QAI.0000000000001446. No abstract available.

48.

IL7RA polymorphisms are not associated with AIDS progression.

Medrano LM, Jiménez JL, Jiménez-Sousa MA, Fernández-Rodíguez A, Gutiérrez-Rivas M, Bellón JM, Blanco JR, Inciarte A, Muñoz-Fernández MÁ, Resino S.

Eur J Clin Invest. 2017 Oct;47(10):719-727. doi: 10.1111/eci.12797. Epub 2017 Sep 2.

PMID:
28796293
49.

Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro.

Lopez-Abente J, Prieto-Sanchez A, Muñoz-Fernandez MÁ, Correa-Rocha R, Pion M.

Cell Mol Immunol. 2018 Oct;15(10):917-933. doi: 10.1038/cmi.2017.48. Epub 2017 Jul 17.

50.

Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.

García-Broncano P, Ceña-Diez R, de la Mata FJ, Gómez R, Resino S, Muñoz-Fernández MÁ.

Eur J Pharmacol. 2017 Sep 15;811:155-163. doi: 10.1016/j.ejphar.2017.05.060. Epub 2017 May 31.

PMID:
28577966

Supplemental Content

Loading ...
Support Center